Breast Cancer Research

Breast Cancer Research: a meeting point as well as a journal

Bruce AJ Ponder

Do we now have a relevant animal model for breast cancer?

Barry Gusterson, Beatrice Howard, Tim Crook, Barbara Tennent

Bringing estrogen receptors under control

Kathryn B Horwitz

Killing the umpire: cooperative defects in mitotic checkpoint and BRCA2 genes on the road to transformation

Frank McKeon

Epithelial stem cells in the mammary gland: casting light into dark corners

Elizabeth Anderson, Robert B Clarke

How many more breast cancer predisposition genes are there?

Douglas F Easton

Endogenous hormones and the aetiology of breast cancer

Timothy J Key, Pia K Verkasalo

Opinion: why the variation in breast cancer survival in Europe?

Michel P Coleman

The pathology of familial breast cancer: The pre-BRCA1/BRCA2 era - historical perspectives

Marc J van de Vijver

The pathology of familial breast cancer: Morphological aspects

Sunil R Lakhani

The pathology of familial breast cancer: Immunohistochemistry and molecular analysis

Pinchas P Osin, Sunil R Lakhani

The pathology of familial breast cancer: The pathology of familial breast cancer How do the functions of BRCA1 and BRCA2 relate to breast tumour pathology?

David Bertwistle, Alan Ashworth

The pathology of familial breast cancer: Clinical and geneticcounselling implications of breast cancer pathology

Fiona Lalloo, D Gareth R Evans

Second International Workshop on the function of BRCA1 and BRCA2, Cambridge, UK, 9 to 10 September 1999

Anastasia Gabriel, Peter Kerr, Madhuri Warren

Late-breaking breast cancer research: from genomics to new drugs

Stephen RD Johnston

The Million Women Study: design and characteristics of the study population

Glutathione S-transferase M1 null genotype: lack of association with tumour characteristics and survival in advanced breast cancer

Sarab Lizard-Nacol, Bruno Coudert, Pascal Colosetti, Jean-Marc Riedinger, Pierre Fargeot, Patrick Brunet-Lecomte

Cyclin D1expression during rat mammary tumor development and its potential role in the resistance of the Copenhagen rat

James E Korkola, Geoffrey A Wood, Michael C Archer

BRCA1 and estrogen receptor signaling

Michael Davies

VEGFR-3 and VEGF-C in angiogenesis

Balvinder Shoker

Mammary gland cell proliferation and steroid receptor expression

Robert Clarke

Risk of breast cancer in women with palpable breast cysts

Emily Banks

Margin width influencing local recurrence in ductal carcinoma in situ

Balvinder Shoker

Interaction of BRCA1 and AR genes in breast cancer risk

Alison Dunning

Report from 16 year UK breast screening trial

Jenny McCann

Tamoxifen treatment for DCIS - NSABP B-24 trial

Balvinder Shoker

Edinburgh breast screening trial, 14 year follow up

Jenny McCann

Impact of mammographic screening in New South Wales

Jenny McCann

Break IT - The Breast Cancer Pathology Information Kit

Lesley Ponton

Raloxifene and breast cancer risk

Emily Banks

LOH in a transgenic model of breast cancer

Michael Davies

Whole-genome scan for common breast cancer?

Alison Dunning

Genetic prodrug activation in erbB-2 overexpressing breast cancer

Richard de Boer

Missing cancers at prevalence screen affects their size at incidence screen

Jenny McCann

ER in normal and pre-cancerous breast

Robert Clarke

Micrometastases and survival in women with primary breast cancer

Emily Banks

MMTV-c-erbB-2 and MMTV-TGF alpha transgenic rats

Michael Davies

Interval cancers in the Scottish screening programme

Jenny McCann

Proliferation markers in preinvasive breast lesions

Balvinder Shoker

BRCA1-associated DNA repair

Chris Jones

Mutations of the TGF-β RI gene are uncommon

Chris Jones

Generation of human tumors in vitro

Valerie Speirs

Pathologic findings from the NSABP B-17 protocol: 8 year update

Balvinder Shoker

Liposome-plasmid complexes encoding angiostatin and endostatin inhibit breast cancer in nude mice

Richard de Boer

ZACdownregulation in breast tumors

Chris Jones

Autologous stem-cell transplantation of hematopoietic cells containing the MDR1 cDNA

Richard de Boer

Stromelysin-1 promotes mammary carcinogenesis

Robert Clarke

Role of the mitotic checkpoint in transformation of Brca2 null cells

Michael Davies

Epstein-Barr virus in breast cancers

Chris Jones

Visibility of cancer on earlier mammograms in the Finnish breast screening programme

Jenny McCann

Idoxifene antagonises E2-dependent breast cancer xenograft growth through apoptosis

Richard de Boer

The effects of HER2 monoclonal antibody in women with HER2-overexpressing metastatic breast cancer

Richard de Boer

Use of cDNA microarrays in breast cancer

Chris Jones

Extracellular matrix modulates mammary gland growth factor signalling

Jenny Gomm

Diet and survival following a diagnosis of breast cancer

Emily Banks

Connexin gap junctions in breast cancer

Robert Clarke

BRCA2overexpression in breast cancer

Chris Jones

Tpl-2overexpression in breast cancer

Chris Jones

High dose chemotherapy in inflammatory breast cancer

Richard de Boer

Adenoviral topoisomerase II αgene transfer increases sensitivity of resistant cancer cells

Richard de Boer

PTEN Immunohistochemistry in Breast Carcinoma

Chris Jones

Apoptosis and caspases in breast cancer

Valerie Speirs

Protein expression mapping of normal human breast epithelium

Rob Clarke

Brca1 and homologous recombination

David Bertwistle

Soya foods and breast cancer risk

Emily Banks

ER and control of cyclin D1 expression

Rob Clarke

Heregulin signalling through HER-2 leads to increased epithelial cell growth

Jenny Gomm

17q aberrations in breast cancer

Chris Jones

bcl-2 and tamoxifen-induced apoptosis

Chris Jones

ErbB-4 dependent proliferation of ER+ breast cells

Mike Davies

Mammary Gland Cell Death Also Involves Lysosomal Autophagy

Reginald Halaby